Increasing evidence for the efficacy of hepatic arterial infusion chemotherapy combined with systemic therapy for advanced hepatocellular carcinoma with macrovascular invasion: time to consider a more effective approach

Kei Moriya; Shinsaku Nagamatsu; Masakazu Uejima; Hideki Matsuo

doi:10.21037/jgo-23-760

Increasing evidence for the efficacy of hepatic arterial infusion chemotherapy combined with systemic therapy for advanced hepatocellular carcinoma with macrovascular invasion: time to consider a more effective approach

J Gastrointest Oncol. 2023 Oct 31;14(5):2282-2286. doi: 10.21037/jgo-23-760. Epub 2023 Oct 10.

Authors

Kei Moriya^{1

2}, Shinsaku Nagamatsu^{1

2}, Masakazu Uejima², Hideki Matsuo^{1

2}

Affiliations

¹ Department of Gastroenterology, Nara Prefecture General Medical Center, Nara, Japan.
² Department of Gastroenterology and Hepatology, Nara Medical University, Kashihara, Japan.

No abstract available

Keywords: Hepatocellular carcinoma (HCC); hepatic arterial infusion chemotherapy (HAIC); immune checkpoint inhibitor (ICI); macrovascular invasion; molecular targeted agents.

Publication types

Editorial
Comment